Recent submissions

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial

Selmaj, Krzysztof W.; Steinman, Lawrence; Comi, Giancarlo; Arnold, Douglas L; Montalban Gairín, Xavier; Bar-Or, Amit; Cree, Bruce (2022-12-09)

Multiple sclerosis; Clinical efficacy; Ozanimod

Inteligencia artificial en esclerosis múltiple

Collorone, Sara; TUR, CARMEN (2024-01-17)

Artificial intelligence; Multiple sclerosis; Magnetic resonance imaging

Economic burden of secondary progressive multiple sclerosis: DISCOVER study

MECA-LALLANA, JOSE EUSTASIO; Oreja-Guevara, Celia; Gómez-Estévez, Irene; Ara Callizo, José Ramón; Hernández Perez, Miguel Angel; Gracia Gil, Julia; Rio, Jordi (2025-05-22)

Direct costs; Progressive multiple sclerosis; Socioeconomic burden

Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study

Calabresi, Peter A.; Green, Ari J.; Kardon, Randy; Sastre Garriga, Jaume; Barkhof, Frederik; Paul, Friedemann (2022-06-27)

Prospective multicenter study; Multiple sclerosis; Tomography

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis

Clarke, Margareta Anna; Prados, Ferran; Alberich Jordà, Manel; Pareto Onghena, Deborah; Rodríguez Barranco, Marta; Tur Gomez, Carmen; Rovira Cañellas, Alex; Sastre Garriga, Jaume; Barkhof, Frederik; Chard, Declan; Calvi, Alberto; Ciccarelli, Olga (2023-04-11)

Chronic active lesions; Multiple sclerosis; Volumetric MRI

Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis

Graves, Jennifer; Ganzetti, Marco; Dondelinger, Frank; Lipsmeier, Florian; Belachew, Shibeshih Mitiku; Montalban Gairín, Xavier; Bernasconi, Corrado (2023-02-21)

Multiple sclerosis

Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders

Gonzalez Escamilla, Gabriel; Mongay-Ochoa, Neus; Fleischer, Vinzenz; Pareto, Deborah; Rovira, Alex; Sastre Garriga, Jaume (2025-10-22)

Grey matter; Morphometric covariance networks; Neurodegeneration

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations

Boaventura de Oliveira, Mateus; Garcia Vidal, Aran; Vidal Jordana, Angela; Quartana, Davide; Carvajal Junco, René Yeltsin; Auger Acosta, Cristina; Alberich Jordà, Manel; Tintore Subirana, Mar; Rovira Cañellas, Alex; Montalban Gairín, Xavier; Pareto Onghena, Deborah; Sastre Garriga, Jaume (2022-07-20)

Clinically isolated syndrome; Magnetic resonance imaging; Multiple sclerosis

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies

Arnaldos-Pérez, Cristina; Vilaseca Jolonch, Andreu; Naranjo, Laura; Sabater, Lidia; Dalmau, Josep; Ruiz-García, Raquel (2023-07-04)

Cell-based assay; Paraneoplastic neurological syndromes; Small-cell lung cancer

The potential of serum neurofilament as biomarker for multiple sclerosis

Bittner, Stefan; Tintore Subirana, Mar; Zipp, Frauke; Oh, Jiwon; Kubala Havrdova, Eva (2022-06-07)

Biomarcadores; Neurofilamento; Respuesta a la terapia

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial

Montalban Gairín, Xavier; Hu, Xixi; Kropshofer, Harald; Kukkaro, Petra; Coello, Neva; Bar-Or, Amit (2023-02-17)

Biomarker; Ofatumumab; Relapsing multiple sclerosis

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis

Hauser, Stephen L.; Montalban Gairín, Xavier; Craveiro, Licinio; Chognot, Cathy; Hughes, Richard; Kappos, Ludwig (2022-07-18)

Multiple sclerosis; Patient safety; Medical care

Quantification of Cervical Cord Cross-Sectional Area: Which Acquisition, Vertebra Level, and Analysis Software? A Multicenter Repeatability Study on a Traveling Healthy Volunteer

Lukas, Carsten; Bellenberg, Barbara; Prados, Ferran; Valsasina, Paola; Parmar, Katrin; Brouwer, Iman; Pareto Onghena, Deborah; Rovira Cañellas, Alex; Sastre Garriga, Jaume (2022-05-02)

Atrofia; Área transversal; Médula espinal

Fluid biomarkers in multiple sclerosis: from current to future applications

Di Filippo, Massimiliano; Gaetani, Lorenzo; Centonze, Diego; Kuhle, Jens; Teunissen, Charlotte; Hegen, Harald; Tintore, Mar (2025-02-11)

Biomarkers; Cerebrospinal fluid; Multiple sclerosis

Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis

Comabella Lopez, Manuel; TUR, CARMEN; Arrambide, Georgina (2025-01-07)

Fluid biomarkers; Artificial intelligence; Multiple scleorsis

Consensus on early detection of disease progression in patients with multiple sclerosis

Casanova, Bonaventura; Rodríguez-Antigüedad, Alfredo; Eichau-Madueño, Sara; Izquierdo, Guillermo; Durán, Carmen; Rio Izquierdo, Jordi; Meca-Lallana, Jose Eustasio (2022-11-03)

Consensus; Early detection; Secondary progressive multiple sclerosis

Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis

Montalban Gairín, Xavier; Solari, Alessandra; Brochet, Bruno; Langdon, Dawn; Piehl, Fredrik; Lechner-Scott, Jeannette; Hupperts, Raymond (2022-07-19)

Cladribine tablets; Relapsing multiple sclerosis; Treatment satisfaction

GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

Ortiz, Didio Alberto; Peregrín, Nuria; Valencia, Miguel; Vinueza-Gavilanes, Rodrigo; Marin-Ordovas, Elisa; Ferrero, Roberto (2025-01-22)

Toxicity; Mouse model; Amyotrophic lateral sclerosis

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study

Midaglia Fernandez, Luciana; Mulero Carrillo, Patricia; Montalban Gairín, Xavier; Graves, Jennifer; Hauser, Stephen L.; Julian, Laura (2020-03-13)

Smartphone; Multiple sclerosis; Patient adherence

Priority setting: women’s health topics in multiple sclerosis

Ross, Lindsay; Cohen, Jeffrey Alan; Hellwig, Kerstin; Finlayson, Marcia; amato, Maria Pia; Tintore, Mar (2024-03-11)

Cancer; Multiple sclerosis; Women’s health

Centre d'Esclerosi Múltiple de Catalunya – CEMCAT: Recent submissions

Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial ﻿

Inteligencia artificial en esclerosis múltiple ﻿

Economic burden of secondary progressive multiple sclerosis: DISCOVER study ﻿

Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study ﻿

Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis ﻿

Preliminary validity of the Draw a Shape Test for upper extremity assessment in multiple sclerosis ﻿

Structural covariance analysis for neurodegenerative and neuroinflammatory brain disorders ﻿

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations ﻿

Algorithm to improve the diagnosis of paraneoplastic neurological syndromes associated with SOX1 antibodies ﻿

The potential of serum neurofilament as biomarker for multiple sclerosis ﻿

Serum Neurofilament Light Trajectories and Their Relation to Subclinical Radiological Disease Activity in Relapsing Multiple Sclerosis Patients in the APLIOS Trial ﻿

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis ﻿

Quantification of Cervical Cord Cross-Sectional Area: Which Acquisition, Vertebra Level, and Analysis Software? A Multicenter Repeatability Study on a Traveling Healthy Volunteer ﻿

Fluid biomarkers in multiple sclerosis: from current to future applications ﻿

Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis ﻿

Consensus on early detection of disease progression in patients with multiple sclerosis ﻿

Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis ﻿

GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model ﻿

Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study ﻿

Priority setting: women’s health topics in multiple sclerosis ﻿